Navigation Links
Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
Date:5/23/2013

SAN DIEGO, May 23, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Deutsche Bank 38th Annual dbAccess Health Care Conference in Boston.  

The live presentation takes place on Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for one month.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Reports First Quarter 2013 Results
2. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
3. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
4. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
5. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
6. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
7. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
8. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
9. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
10. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... ... AseptiScope, a privately funded San Diego, California based, clinical innovation company, has ... , “AseptiScope is pleased to receive this recognition,” said Kelly Powers, AseptiScope cofounder ... hands, goggles on their eyes, covers on their shoes, and gowns on their bodies ...
(Date:8/26/2020)... ... August 26, 2020 , ... Clinical ... definitive agreement to acquire ProCE, a nationally recognized provider of continuing education ... , CEA represents a growing alliance of CME/CE and service organizations that ...
(Date:8/26/2020)... ... ... Hero Life Sciences announced today that it will be setting ... face masks and N95 respirators in its manufacturing plant located in the City of ... are facing in trying to find quality disposable face masks during the COVID-19 pandemic ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... The growing adoption of ... Fall 2020 Virtual Conference, a two-day virtual event for radiology professionals that will ... is the follow-up to AuntMinnie.com's successful virtual event in spring 2020, in which ...
(Date:9/3/2020)... ... , ... International Dark-Sky Association (IDA) recently bestowed the prestigious ... advanced LED wireless dimming controller, along with the previously IDA approved Dimulator, are ... light pollution. Leo Smith, the Northeast Regional Director for IDA says “We are ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... completed $3 million convertible note financing, which will be used to accelerate the ... funds from this financing, the company will continue to expand its customer base ...
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. ... training in aesthetic surgery of the face, breast, and body. In 2018, she ... premier boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill and ...
(Date:8/31/2020)... ... , ... Just found out your dear friend has cancer? , It’s hard to hear your ... shares their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. ... best ways to help? Words are failing me. I’m scared. I want to DO something. ...
Breaking Medicine News(10 mins):